A Neurotrophic & Nootropic Formulation with BDNF and NGF mRNA Expression Enhancement Features for the Treatment of Neurological Damage & Development Disorders BDNF NGF Neurotrophin
Description
A Neurotrophic and Nootropic Formulation consisting of a Pro-Somathropic Dioscin Analouge with increased systemic duration due to prolonged half-life, a Gymnemic Acid Analouge with BDNF NGF and Neurotrophin B3 mRNA Expression Enhancing Properties. Formulation may serve as an adjuvant curative means for Neurological Development Defects along with Chronical Cerebrospinal Ailments like Dementia, Neuromascular Defects and other Neurodegenerative Disorders.
Author
This dataset has been published on the initiative and under the responsibility of
Erdal Can Alkoclar
Published on April 23, 2020 and updated on September 1, 2021
Latest update
April 23, 2020
License
Creative Commons Attribution Share-Alike 4.0
Metadata quality:
Data description filled
Files documentation missing
License filled
Update frequency not followed
File formats are closed
Temporal coverage not set
Spatial coverage not set
All files are available
Metadata quality
Files documentation missing
Update frequency not followed
File formats are closed
Temporal coverage not set
Spatial coverage not set
There are no reuses for this dataset yet.
There are no discussions for this dataset yet.
There are no community resources for this dataset yet.
Information
Tags
ID
5ea12564d2bfb2355de2bc6f
Temporality
Creation
April 23, 2020
Frequency
Biannual
Latest update
April 23, 2020